Project Grant HT94252310368
Award Date
6/1/23
Completion Date
5/31/25
Dollars Obligated
$316K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19122, USA
Similar Awards
This federal Project Grant award of $434,499.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports research by Temple University-Of The Commonwealth System Of Higher Education to investigate the "RESTORATION OF ALVEOLAR TYPE II CELL FUNCTION IN EMPHYSEMA". The project aims to transform healthcare for military service members, veterans, and the broader public by conducting advanced biomedical research...
Temple University was awarded a $2.53 million Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research into the role of TRAF6 in primary alveolar epithelial cell injury from September 2021 through September 2025. As part of the Military Medical Research and Development program's goals to transform military and public health through innovative medical research, this project will...
The federal Project Grant award of $1,585,000.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award, effective March 1, 2025 through February 28, 2029, supports advanced biomedical research at Temple University-Of The Commonwealth System Of Higher Education aimed at "TARGETING LYMPHATIC CHEMOKINE SIGNALING TO PROMOTE LYMPHANGIOGENESIS FOR THE TREATMENT OF LYMPHEDEMA". The grant funding will enable Temple...
The U.S. Defense Health Agency awarded a $1,999,996 Project Grant to Temple University under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research to identify diagnostic biomarkers of cerebrovascular contributions to cognitive impairment in repeated blast concussion. This 4-year research project, running from June 2025 to May 2029, aims to transform healthcare for military service members, veterans, and the broader public by...
This federal Project Grant award of $435,876.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award, effective March 1, 2025 through February 28, 2027, supports advanced biomedical research by Temple University to investigate KIF11, a novel therapeutic target for lymphedema. The research aims to transform healthcare for military service members, veterans, and the broader public by developing innovative solutions to...
The Defense Health Agency awarded a $634,000 Project Grant under the Military Medical Research and Development (CFDA 12.420) federal grant program to Temple University. The grant, titled "Cellular and Molecular Heterogeneity in Esophageal Epithelium as a Contributor to Racial Disparities in Esophageal Cancer," will support research focused on addressing racial disparities in esophageal cancer from September 2024 to September 2026. As a prominent public research university, Temple...
This Project Grant award from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) provides $434,492 to Temple University to conduct research on "Mitochondrial Transplantation as a Novel Therapy for Lung Fibrosis". The award period runs from June 1, 2025 to May 31, 2027. The Military Medical Research and Development program supports advanced biomedical research to transform healthcare for military service members, veterans, and the broader public. This...
The Department of the Army Medical Command awarded a $1,188,750.00 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to Temple University to support research aimed at identifying therapeutic peptide drugs for regenerating visual pathways. The award, effective September 15, 2024, will fund this initiative over a 3-year period through September 14, 2027. As a prominent public research university, Temple University has extensive experience conducting advanced...
This Project Grant award in the amount of $679,085.00 was issued by the Defense Health Agency, a component of the Department of Defense, under the Military Medical Research and Development program (CFDA 12.420). The funding supports research by Temple University-Of The Commonwealth System Of Higher Education, through its division Temple University, to investigate the role of tumor-associated sensory neurons in breast cancer invasion and metastasis. The award period runs from January 15, 2024...
The Trustees of the University of Pennsylvania will receive $975,000 through a three-year Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will support lung cancer research from July 1, 2023 to June 30, 2026. Through this funding, the University and its Clinical Practices will conduct biomedical research to transform service member healthcare and investigate medical solutions applicable to battlefield medicine....